Moscow Exchange

MD Medical Group Investments Plc: MD Medical Group announces cancellation of listing on LSE

Retrieved on: 
Thursday, June 22, 2023

MD Medical Group Investments Plc: MD Medical Group announces cancellation of listing on LSE

Key Points: 
  • MD Medical Group Investments Plc: MD Medical Group announces cancellation of listing on LSE
    22 June 2023 – MD Medical Group Investments Plc (“MD Medical Group”, “MDMG”, the “Group” or the “Company” – MOEX: MDMG), a leading Russian private healthcare provider, further to the announcement made on 23 May 2023 [1] , today announces that following its applications submitted to the UK Financial Conduct Authority (the “FCA”) and the London Stock Exchange (the “LSE”), the Company’s global depositary receipts (the “GDRs”) (ISIN US55279C2008 and ISIN US55279C1018) were cancelled from the FCA’s official list and admission to trading on the LSE with effect from 8:00 a.m. (London time) on 22 June 2023.
  • Trading in Company’s GDRs will continue on the regulated market of Moscow Exchange.
  • The rights of GDR holders under this security remain unchanged.
  • For further information please contact:

Yandex announces favorable decision of Nasdaq Listing Hearings Panel

Retrieved on: 
Saturday, June 10, 2023

Amsterdam, June 8, 2023 – As previously disclosed, on March 15, 2023, Yandex N.V. (“Yandex”) received a written notice (the “Notice”) from the Listing Qualifications Staff (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Staff had determined that the Company’s Class A ordinary shares would be delisted from The Nasdaq Stock Market.

Key Points: 
  • Amsterdam, June 8, 2023 – As previously disclosed, on March 15, 2023, Yandex N.V. (“Yandex”) received a written notice (the “Notice”) from the Listing Qualifications Staff (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Staff had determined that the Company’s Class A ordinary shares would be delisted from The Nasdaq Stock Market.
  • On April 27, 2023, a hearing was held before the Nasdaq Hearings Panel in connection with Yandex’s appeal of the Staff’s determination.
  • On June 6, 2023, Yandex received notification of the Hearings Panel’s decision to grant the request of Yandex to continue its listing on Nasdaq, subject to certain conditions related to the timing and implementation of Yandex’s proposed corporate restructuring, including the divestment of ownership and control of a number of our core businesses, including all Russia-based businesses, by the end of 2023.
  • The trading of Yandex N.V.’s Class A shares on the Moscow Exchange is unaffected and continues as usual.

MD Medical Group Investments Plc: MD Medical Group announces intention to delist GDRs from the LSE

Retrieved on: 
Saturday, May 27, 2023

MD Medical Group Investments Plc: MD Medical Group announces intention to delist GDRs from the LSE

Key Points: 
  • MD Medical Group Investments Plc: MD Medical Group announces intention to delist GDRs from the LSE
    23 May 2023 – MD Medical Group Investments Plc (“MD Medical Group”, “MDMG”, the “Group” or the “Company” – LSE and MOEX: MDMG), a leading Russian private healthcare provider, announces its intention to cancel the listing of Global Depositary Receipts (the “GDRs”) on the London Stock Exchange.
  • As a result of the prolonged suspension of trading of the Company’s GDRs on the London Stock Exchange and the consequent inability of investors to trade these securities on this exchange the Company has taken the decision to cancel the listing of the GDRs.
  • Pursuant to Listing Rule 5.2.8R, the Company is required to give at least 20 business days' notice of the intended Cancellation of Listing.
  • Following the LSE Listing Cancellation, trading in Company’s GDRs will continue on the regulated market of Moscow Exchange.

Cian PLC Announces First Quarter 2023 Financial Results

Retrieved on: 
Friday, May 19, 2023

Cian PLC (NYSE: CIAN, MOEX: CIAN) (“Cian”, the “Group” or the “Company”), a leading online real estate classifieds platform in Russia, today announced its financial results for the first quarter ended March 31, 2023.

Key Points: 
  • Cian PLC (NYSE: CIAN, MOEX: CIAN) (“Cian”, the “Group” or the “Company”), a leading online real estate classifieds platform in Russia, today announced its financial results for the first quarter ended March 31, 2023.
  • Dmitriy Grigoriev, Chief Executive Officer of Cian PLC, commented: “Our business continues to show steady revenue growth backed by positive signals of a gradual demand recovery.
  • Among other things, it sets the backdrop to allow our business to continue growing at a good pace.
  • See “Non-IFRS Financial Measures and Supplemental Financial Information” elsewhere in this release for a description of these measures and their reconciliation from the most directly comparable IFRS financial measures.

MD Medical Group Investments Plc: MD Medical Group launches the procedure for changing the GDR program depositary

Retrieved on: 
Saturday, April 15, 2023

MD Medical Group Investments Plc: MD Medical Group launches the procedure for changing the GDR program depositary

Key Points: 
  • MD Medical Group Investments Plc: MD Medical Group launches the procedure for changing the GDR program depositary
    10 April 2023 – MD Medical Group Investments Plc (“MD Medical Group,” “MDMG,” the “Group” or the “Company” – LSE and MOEX: MDMG), a leading Russian private healthcare provider, announces the launch of the procedure for changing the depository bank that administers the Company’s Global Depositary Receipts (GDR) program.
  • The currently appointed depositary bank managing the Company’s GDR program is JPMorgan Chase Bank N.A.
  • has been appointed as the new depositary bank.
  • Holders of MDMG’s GDRs are not required to take any additional actions in connection with the procedure for changing the depositary bank, which will take approximately 120 days.

PhosAgro PJSC: Independent Director Viktor Cherepov Re-elected Chairman of PhosAgro’s Board of Directors

Retrieved on: 
Saturday, April 15, 2023

Moscow – The Board of Directors of PhosAgro (Moscow Exchange, LSE: PHOR), one of the world’s leading vertically integrated phosphate-based fertilizer producers, re-elected the independent director Viktor Cherepov as its Chairman at its first meeting since the Company’s Annual General Meeting of Shareholders.

Key Points: 
  • Moscow – The Board of Directors of PhosAgro (Moscow Exchange, LSE: PHOR), one of the world’s leading vertically integrated phosphate-based fertilizer producers, re-elected the independent director Viktor Cherepov as its Chairman at its first meeting since the Company’s Annual General Meeting of Shareholders.
  • Alexander Sharabaiko was re-elected Deputy Chairman of the Board of Directors.
  • The independent director Viktor Cherepov was re-elected Chairman of the Audit Committee; Siroj Loikov was elected Chairman of the Remuneration and Human Resources Committee; and Alexander Sharabaiko was re-elected Chairman of the Strategy and Sustainable Development Committee.
  • The Board of Directors also recognised Vladimir Trukhachev as an independent director in accordance with the provisions of the Corporate Governance Code and the Listing Rules of Moscow Exchange.

PhosAgro PJSC: PhosAgro Successfully Debuts on Russian Debt Market with Yuan-Denominated Bonds

Retrieved on: 
Saturday, April 15, 2023

Moscow – PhosAgro (Moscow Exchange, LSE: PHOR), one of the world’s leading vertically integrated phosphate-based fertilizer producers, announces that it successfully completed the book build for its first-ever issue of exchange-traded bonds in the amount of CNY 2 billion on Moscow Exchange.

Key Points: 
  • Moscow – PhosAgro (Moscow Exchange, LSE: PHOR), one of the world’s leading vertically integrated phosphate-based fertilizer producers, announces that it successfully completed the book build for its first-ever issue of exchange-traded bonds in the amount of CNY 2 billion on Moscow Exchange.
  • The bonds have a par value of CNY 1,000, a coupon period of 91 days and maturity in three years.
  • Mikhail Rybnikov, CEO and Chairman of the Management Board of PhosAgro, said:
    “Amid the current environment, we had quite a successful debut on Moscow Exchange with foreign-currency bonds.
  • In so doing, we have discovered a new space for raising capital on terms that are comfortable for the Company.”

PhosAgro PJSC: PhosAgro Receives First-Ever Credit Rating from Expert RA: AAA (RU) with Stable Outlook

Retrieved on: 
Friday, March 31, 2023

PhosAgro PJSC: PhosAgro Receives First-Ever Credit Rating from Expert RA: AAA (RU) with Stable Outlook

Key Points: 
  • PhosAgro PJSC: PhosAgro Receives First-Ever Credit Rating from Expert RA: AAA (RU) with Stable Outlook
    The issuer is solely responsible for the content of this announcement.
  • PhosAgro Receives First-Ever Credit Rating from Expert RA: AAA (RU) with Stable Outlook
    Moscow – PhosAgro (Moscow Exchange, LSE: PHOR), one of the world’s leading vertically integrated phosphate-based fertilizer producers, announces that the credit rating agency Expert RA has assigned PhosAgro a credit rating for the first time: the AAA rating (with a stable outlook) is the highest possible on Russia’s national scale: https://raexpert.ru/releases/2023/mar30b.
  • Earlier, PhosAgro also received a AAA(RU) rating with a stable outlook from ACRA.

Cian PLC Announces Fourth Quarter and Full Year 2022 Financial Results

Retrieved on: 
Thursday, March 30, 2023

Cian PLC (NYSE: CIAN, MOEX: CIAN) (“Cian”, the “Group” or the “Company”), a leading online real estate classifieds platform in Russia, today announced its financial results for the fourth quarter and twelve months ended December 31, 2022.

Key Points: 
  • Cian PLC (NYSE: CIAN, MOEX: CIAN) (“Cian”, the “Group” or the “Company”), a leading online real estate classifieds platform in Russia, today announced its financial results for the fourth quarter and twelve months ended December 31, 2022.
  • Dmitriy Grigoriev, Chief Executive Officer of Cian PLC, commented: “2022 was challenging for us in many aspects and I am very proud and grateful to the management team for their dedication, professionalism and hard work which allowed us to deliver strong results in this unprecedently unpredictable market environment.
  • Our financial results speak for themselves, not only we achieved almost 40% revenue growth Y-o-Y, but also significantly improved marginality of our business with adjusted EBITDA margin reached 20%.
  • The Company utilized its right to a review of the determination and, accordingly, filed an appeal to this decision.

Cian Announces Submission of Appeal to NYSE Delisting Determination

Retrieved on: 
Tuesday, March 28, 2023

As previously announced, the Company received a written notice of such determination by the Staff on March 15, 2023.

Key Points: 
  • As previously announced, the Company received a written notice of such determination by the Staff on March 15, 2023.
  • The delisting of the Company’s securities will be stayed pending the conclusion of the review process, while the trading suspension that was implemented on February 28, 2022 will remain in effect.
  • There can be no assurance that the Committee will grant the Company’s request for continued listing on the NYSE.
  • The trading of the Company’s ADSs on the Moscow Exchange is unaffected and continues as usual.